A Study to Investigate the Efficacy and Tolerability of ESO-101 in Patients With Eosinophilic Esophagitis
- First Posted Date
- 2021-04-19
- Last Posted Date
- 2023-11-14
- Lead Sponsor
- EsoCap AG
- Target Recruit Count
- 43
- Registration Number
- NCT04849390
- Locations
- 🇳🇱
Amsterdam University Medical Center, Amsterdam, Netherlands
🇩🇪Universitätsklinikum Leipzig AöR, Leipzig, Germany
🇩🇪Facharztzentrum Eppendorf, Hamburg, Germany
© Copyright 2025. All Rights Reserved by MedPath